Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Its primary focus is on developing first-in-class oral peptide drugs that specifically target biological pathways also targeted by currently marketed injectable antibody drugs... Read more
Protagonist Therapeutics to Present at the Oppenheimer & Co. Healthcare Conference read more
Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results read more
Protagonist Therapeutics to Present at the Barclays Global Healthcare Conference read more
There are currently no events scheduled.
|Data provided by Nasdaq. Minimum 15 minutes delayed.|